Search results
4 days ago · Witten joins four other current HHMI Investigators on the Princeton faculty: Bonnie Bassler, the Squibb Professor in Molecular Biology and chair of the Department of Molecular Biology; Cliff Brangwynne, the June K. Wu ’92 Professor of Chemical and Biological Engineering and director of Princeton’s Omenn-Darling Bioengineering Institute; Carlos B...
4 days ago · Witten joins four other current HHMI Investigators on the Princeton faculty: Bonnie Bassler, the Squibb Professor in Molecular Biology and chair of the Department of Molecular Biology; Cliff Brangwynne, the June K. Wu ’92 Professor of Chemical and Biological Engineering and director of Princeton's Omenn-Darling Bioengineering Institute; Carlos Brody, the Wilbur H. Gantz III ’59 Professor ...
4 days ago · Witten is currently one of five HHMI investigators at Princeton University, alongside notable colleagues such as Bonnie Bassler in molecular biology, Cliff Brangwynne in chemical and biological engineering, Carlos Brody in neuroscience, and Martin Jonikas in molecular biology. The Importance of Research on Brain Circuits
5 days ago · Chromobacterium violaceum is commonly found in soil and freshwater within tropical and subtropical regions. Although not a common occurrence, this bacterium has the potential to cause severe diseases in humans and animals, such as liver and lung abscesses and septicemia. Herein we report the synthesis of novel N-acyl homoserine lactones (HSLs) to evaluate their effectiveness as antiquorum ...
3 days ago · Also, Director Bonnie L. Bassler sold 827 shares of the business's stock in a transaction that occurred on Wednesday, June 5th. The shares were sold at an average price of $1,011.00, for a total value of $836,097.00.
18 hours ago · bonnie bassler cerevel therapeutics holdings, inc. n. coles the sherwin-williams company ...
3 days ago · In other Regeneron Pharmaceuticals news, Director Bonnie L. Bassler sold 756 shares of the firm’s stock in a transaction dated Monday, June 24th. The shares were sold at an average price of $1,062.00, for a total value of $802,872.00. Following the transaction, the director now owns 1,382 shares of the company’s stock, valued at $1,467,684.
